Aspiriant LLC’s Raytheon Company RTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-7,279
Closed -$955K 201
2020
Q1
$955K Sell
7,279
-1,869
-20% -$370K 0.09% 82
2019
Q4
$2M Sell
9,148
-398
-4% -$84.1K 0.19% 60
2019
Q3
$1.88M Sell
9,546
-743
-7% -$138K 0.17% 75
2019
Q2
$1.78M Sell
10,289
-884
-8% -$159K 0.15% 80
2019
Q1
$2.04M Sell
11,173
-770
-6% -$134K 0.17% 79
2018
Q4
$1.84M Sell
11,943
-1,936
-14% -$347K 0.14% 81
2018
Q3
$2.85M Sell
13,879
-715
-5% -$142K 0.24% 66
2018
Q2
$2.82M Sell
14,594
-588
-4% -$124K 0.24% 64
2018
Q1
$3.28M Buy
15,182
+13,968
+1,151% +$2.89M 0.29% 56
2017
Q4
$228K Sell
1,214
-16,068
-93% -$3M 0.07% 73
2017
Q3
$3.22M Sell
17,282
-3,985
-19% -$702K 0.27% 53
2017
Q2
$3.43M Sell
21,267
-1,936
-8% -$307K 0.3% 52
2017
Q1
$3.54M Sell
23,203
-3,210
-12% -$483K 0.3% 57
2016
Q4
$3.75M Sell
26,413
-4,725
-15% -$671K 0.34% 46
2016
Q3
$4.24M Sell
31,138
-6,252
-17% -$869K 0.42% 38
2016
Q2
$3.58M Sell
37,390
-159
-0.4% -$20.7K 0.34% 51
2016
Q1
$4.61M Buy
+37,549
New +$4.62M 0.44% 36

Other funds holding RTN

Aspiriant LLC's RTN Position: Q2 2020 in Review

Aspiriant LLC sold out of Raytheon Company (RTN) in Q2 2020, closing a stake of 7,279 shares — an estimated $955K sold.

Aspiriant LLC first reported a position in RTN in Q1 2016 and held it in 17 quarters. The position peaked at $4.61M in Q1 2016. 75 funds tracked by Wall St. Rank hold RTN as of Q2 2020.

  • Aspiriant LLC reported no remaining Raytheon Company position as of Q2 2020 after selling out during the quarter.
  • Aspiriant LLC sold 7,279 Raytheon Company shares in Q2 2020, an estimated $955K.
  • Aspiriant LLC first reported a position in Raytheon Company in Q1 2016 and held it in 17 quarters.
  • Aspiriant LLC's Raytheon Company position peaked at $4.61M in Q1 2016.
  • 75 funds tracked by Wall St. Rank held Raytheon Company as of Q2 2020.

Based on Aspiriant LLC's 13F filing for Q2 2020, filed 6 Aug 2020.